GO:0016763 pentosyltransferase activity: Mechanism, Genes and Research Methods

Research-grade guide for scientists and biopharma professionals

Key Takeaways

GO:0016763 (pentosyltransferase activity) describes enzymes that transfer a pentosyl group from a donor to an acceptor, a reaction class that includes many glycosyltransferases and nucleotide-sugar-dependent enzymes.
Pentosyltransferases such as XYLT1 use UDP-xylose to modify proteoglycans, and this activity can feed into NF-kB signaling and promote early-stage lung adenocarcinoma metastasis.
The term is a molecular_function node in the Gene Ontology, with the synonym transferase activity, transferring pentosyl groups, and it sits upstream of many cell-surface and extracellular matrix processes.
Dysregulated pentosyltransferase activity has been linked to cancer progression, extracellular matrix remodeling, and metabolic stress responses, making it a target for functional genomics.
CRISPR knockout, point-mutation, knock-in, and overexpression models are the primary tools for dissecting the causal roles of pentosyltransferase genes in disease.
EDITGENE provides end-to-end CRISPR cell model and library screening services to study pentosyltransferase activity in a publication-ready format.

Description

Pentosyltransferase activity (GO:0016763) is a molecular function defined as the catalysis of the transfer of a pentosyl group from one compound (donor) to another (acceptor). This activity is central to the biosynthesis and remodeling of glycoconjugates, including proteoglycans and glycoproteins, and it is carried out by enzymes that often use nucleotide-sugar donors such as UDP-xylose. Because pentosyltransferases modify extracellular and cell-surface molecules, their activity can influence cell signaling, matrix architecture, and tissue homeostasis. Researchers study this term to understand how glycosylation events contribute to development, cancer, and metabolic disease. The Gene Ontology annotation provides a standardized way to classify these enzymes and to connect them to broader biological processes.

pentosyltransferase activity At A Glance

GO ID GO:0016763
GO term pentosyltransferase activity
Ontology molecular_function
Synonym transferase activity, transferring pentosyl groups
Major function Transfer of a pentosyl group from a donor to an acceptor
Example enzyme XYLT1, a xylosyltransferase that modifies proteoglycans
Pathway context Glycosylation and extracellular matrix remodeling
Disease relevance Cancer metastasis and matrix-related pathologies

What Is GO:0016763?

In plain terms, pentosyltransferase activity means an enzyme picks up a five-carbon sugar unit (a pentosyl group) from a donor molecule and attaches it to a different molecule, the acceptor. The QuickGO definition states: Catalysis of the transfer of a pentosyl group from one compound (donor) to another (acceptor). This activity is a type of transferase activity and is often synonymous with transferase activity, transferring pentosyl groups. It is classified under the molecular_function aspect of the Gene Ontology.

Why Is pentosyltransferase activity Important in Cell Biology?

Pentosyltransferase activity matters because it governs the addition of pentose sugars to proteins and lipids, a modification that can alter protein stability, localization, and interaction with signaling partners. For example, XYLT1-mediated xylosylation of proteoglycans can activate NF-kB signaling and promote metastasis in early-stage lung adenocarcinoma, illustrating how a single pentosyltransferase can drive tumor progression. Beyond cancer, these enzymes contribute to extracellular matrix assembly and cell-surface recognition events that are fundamental to tissue development and repair. Understanding pentosyltransferase activity therefore provides mechanistic insight into diseases where glycosylation is perturbed and offers potential targets for therapeutic intervention.
Pentosyltransferases modify proteoglycans and glycoproteins, affecting cell signaling and matrix properties.
XYLT1, a pentosyltransferase, activates NF-kB signaling to promote lung adenocarcinoma metastasis.
Altered glycosylation is a hallmark of cancer and can influence immune recognition and invasion.
These enzymes are involved in extracellular matrix remodeling, relevant to arthritis and fibrosis.
Pentosyltransferase activity can impact growth factor signaling by modifying receptor co-receptors.
Genetic variants in pentosyltransferase genes are associated with connective tissue disorders.
The activity is a potential biomarker for early-stage cancers and a target for drug discovery.
CRISPR screens can identify pentosyltransferase dependencies in specific cancer contexts.

What Happens During pentosyltransferase activity?

Donor recognition and binding
In simple terms: The enzyme first grabs the sugar donor molecule.
Pentosyltransferases typically bind a nucleotide-sugar donor such as UDP-xylose, positioning the pentosyl group for transfer. This step is often mediated by conserved residues in the enzyme active site that coordinate the nucleotide moiety and the sugar. For XYLT1, the donor is UDP-xylose, and binding is a prerequisite for subsequent transfer to the acceptor.
Acceptor selection
In simple terms: The enzyme then chooses the target molecule to modify.
The acceptor can be a protein, lipid, or another sugar chain, and specificity is determined by the enzyme's acceptor-binding pocket. In proteoglycan biosynthesis, the acceptor is often a serine residue on a core protein, and the pentosyl group is transferred to initiate glycosaminoglycan chain formation. This step ensures that the pentosyl group is attached to the correct molecular context.
Catalytic transfer and product release
In simple terms: The sugar unit is moved onto the acceptor, and the products are released.
The transfer reaction proceeds through a mechanism that often involves a conserved aspartate or glutamate residue acting as a general base. After transfer, the modified acceptor and the nucleotide byproduct are released, allowing the enzyme to cycle. In the case of XYLT1, the xylosylated proteoglycan can then serve as a substrate for further glycosylation steps.
Downstream signaling consequences
In simple terms: The modification can change how the cell behaves.
Pentosyltransferase activity can alter cell signaling; for instance, XYLT1-mediated modification of proteoglycans activates NF-kB signaling, which promotes metastasis in early-stage lung adenocarcinoma. This illustrates how a single enzymatic event can have profound effects on gene expression and cell fate. Such downstream effects are context-dependent and are a major focus of current research.

Key Genes Involved in GO:0016763 pentosyltransferase activity

The following genes encode enzymes with pentosyltransferase activity or are directly related to this function, based on published literature.
GeneMajor RoleResearch Relevance
XYLT1Xylosyltransferase that transfers xylose to proteoglycansPromotes metastasis in lung adenocarcinoma via NF-kB
XYLT2Xylosyltransferase involved in glycosaminoglycan biosynthesisPotential role in connective tissue disorders
B4GALT7Beta-1,4-galactosyltransferase that can transfer galactose, not pentose, but related to glycosylationUsed as a comparative control in glycosylation studies
SIRT1Deacetylase, not a pentosyltransferase, but cited in related metabolic studiesIndirectly linked to NAD+ metabolism
SIRT3Mitochondrial deacetylase, not a pentosyltransferaseStudied in exercise and aging
PARP1Poly(ADP-ribose) polymerase, transfers ADP-ribose, not pentoseInhibited by exermiR-129-3p to improve muscle function
SOD2Superoxide dismutase, acetylation affects exercise capacityNot a pentosyltransferase but related to redox biology
NF-kBTranscription factor activated downstream of XYLT1Central to inflammation and cancer
ADIPOKINESSignaling molecules in metabolismNot directly pentosyltransferases but studied in metabolic contexts
Resveratrol targetsSIRT1 activatorsUsed in aging research
Osteoarthritis markersMatrix-related proteinsRelevant to extracellular matrix remodeling
ExermiR-129-3pmicroRNA affecting mitochondrial activityNot a pentosyltransferase but cited for muscle function
SIRT1 activatorsCompounds that modulate sirtuin activityStudied in metabolic disease
SIRT3 in exerciseMitochondrial adaptationLinks metabolism to aging
Resveratrol-like compoundsSIRT1 activationPotential anti-aging agents
SOD2 acetylationRedox regulationImpacts exercise capacity in heart failure

How Is pentosyltransferase activity Regulated?

Pentosyltransferase activity is regulated at multiple levels, including enzyme expression, substrate availability, and post-translational modifications. For example, the expression of XYLT1 can be modulated by oncogenic signaling, and its activity is dependent on the availability of UDP-xylose. Additionally, the activity can be influenced by the cellular metabolic state, as nucleotide-sugar donors are products of central carbon metabolism. While specific regulatory mechanisms vary by enzyme, the general principle is that pentosyltransferase activity is tightly coupled to the cell's biosynthetic demands and signaling environment.

pentosyltransferase activity and Human Disease

GeneDisease / BiologyPotential Experimental Model
XYLT1Lung adenocarcinoma metastasisKnockout in A549 or H1299 cells
XYLT2Connective tissue disordersKnockout in fibroblasts
NF-kBInflammation and cancerReporter assays in cancer cell lines
SIRT1Metabolic syndrome and aging [2,7]Overexpression in adipocytes
SOD2Heart failure and exercise capacityPoint mutation in mouse models
Cancer metastasis
XYLT1, a pentosyltransferase, activates NF-kB signaling to promote metastasis of early-stage lung adenocarcinoma, suggesting that inhibitors of this activity could reduce metastatic spread. This finding highlights the potential of targeting pentosyltransferases in oncology.
Extracellular matrix disorders
Pentosyltransferases are essential for proteoglycan biosynthesis, and defects in these enzymes can lead to connective tissue disorders characterized by abnormal matrix assembly. Research in osteoarthritis has highlighted the importance of matrix biology, where glycosylation changes may contribute to disease progression.
Metabolic and aging-related conditions
Although not directly pentosyltransferases, related enzymes such as sirtuins and PARP1 are studied in the context of metabolism and aging, and they share the use of nucleotide-derived substrates [2,4,6]. This suggests a broader theme of nucleotide-sugar and NAD+ metabolism in age-related diseases [2,6].

From pentosyltransferase activity-Related Genes to Experimental Models

Research QuestionSuitable Model
Does loss of XYLT1 reduce metastasis?XYLT1 knockout in lung cancer cell lines
Does a specific point mutation abolish catalytic activity?Point-mutation knock-in of XYLT1 active-site residue
Can a tagged version track localization?Knock-in of FLAG-tagged XYLT1
Does overexpression enhance NF-kB signaling?XYLT1 overexpression in HEK293T cells
Which glycosylation pathways are affected?CRISPR library screening for glycosyltransferases
Does SIRT1 activation mimic pentosyltransferase effects?SIRT1 overexpression or activator treatment [2,7]

How to Study the pentosyltransferase activity Process

MethodWhat It MeasuresTypical Application
Enzymatic assay with UDP-xyloseTransferase activityValidation of XYLT1 function
Mass spectrometry glycomicsGlycan compositionDetecting pentose modifications
CRISPR knockout screenGene essentialityIdentifying pentosyltransferase dependencies
NF-kB luciferase reporterNF-kB transcriptional activityLinking XYLT1 to signaling
Western blotProtein expression and phosphorylationConfirming pathway activation
ImmunofluorescenceProtein localizationVisualizing tagged enzymes
RNA-seqTranscriptome changesGlobal effects of enzyme loss
ProteomicsProtein abundance and modificationsIdentifying downstream targets
Enzymatic activity assays
Pentosyltransferase activity can be measured using radioactive or fluorescent donor substrates, followed by chromatographic separation of products. These assays are used to confirm the catalytic function of candidate enzymes and to test inhibitors.
Glycosylation profiling
Mass spectrometry-based glycomics and lectin blotting can reveal changes in pentose-containing glycans upon genetic manipulation. Such profiling is essential to link enzyme activity to specific glycan structures.
CRISPR screening
Genome-wide CRISPR knockout screens can identify pentosyltransferase genes that are essential for cancer cell growth or metastasis. These screens provide unbiased functional evidence for gene involvement.
Signaling pathway analysis
NF-kB reporter assays and Western blotting for phosphorylated NF-kB can determine whether pentosyltransferase activity modulates inflammatory signaling. This approach connects enzymatic function to downstream transcriptional programs.

How CRISPR Can Be Used to Study GO:0016763 pentosyltransferase activity

Knockout

CRISPR knockout of pentosyltransferase genes such as XYLT1 can abolish enzymatic activity and reveal loss-of-function phenotypes, including reduced metastasis in cancer models. Knockout cell lines are essential for validating gene function.

Point Mutation

Introducing point mutations in the catalytic domain of a pentosyltransferase can separate enzymatic activity from scaffolding functions. This approach helps determine whether the transferase activity itself is required for a phenotype.

Knock-in

Knock-in of epitope tags or fluorescent proteins allows tracking of endogenous pentosyltransferase expression and localization. This is useful for studying dynamic regulation in live cells.

Overexpression

Overexpression of wild-type or mutant pentosyltransferases can test gain-of-function effects, such as enhanced NF-kB signaling and metastasis. Overexpression models are complementary to knockout studies.

How EDITGENE Supports pentosyltransferase activity Research

Researchers studying pentosyltransferase activity-related genes often need to determine whether a candidate gene is causally involved in a disease phenotype, and CRISPR-based cell models provide the most direct way to test this. EDITGENE offers a comprehensive suite of services to generate such models efficiently.
Contact EDITGENE today to design your custom CRISPR model for pentosyltransferase activity research.

Frequently Asked Questions About pentosyltransferase activity

Pentosyltransferase activity (GO:0016763) is the catalysis of the transfer of a pentosyl group from a donor to an acceptor, as defined by the Gene Ontology.
Genes such as XYLT1 and XYLT2 encode enzymes with this activity, and they modify proteoglycans.
XYLT1, a pentosyltransferase, activates NF-kB signaling to promote metastasis in early-stage lung adenocarcinoma.
Dysregulated activity has been linked to cancer metastasis and extracellular matrix disorders.
Common methods include enzymatic assays, mass spectrometry glycomics, CRISPR screens, and signaling reporter assays.
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to dissect gene function.
The GO ID is GO:0016763.
Yes, it is classified under the molecular_function aspect of the Gene Ontology.
The synonym is transferase activity, transferring pentosyl groups.
EDITGENE provides CRISPR cell model generation, library screening, and bioinformatics services tailored to pentosyltransferase genes.

Conclusion

Pentosyltransferase activity (GO:0016763) is a fundamental molecular function that mediates the transfer of pentose sugars to diverse acceptors, with critical roles in proteoglycan biosynthesis and cell signaling. Its dysregulation has been implicated in cancer metastasis and matrix-related diseases, making it a compelling target for functional genomics. By leveraging CRISPR-based models and high-throughput screening, researchers can uncover the precise contributions of pentosyltransferases to human disease and identify new therapeutic opportunities.

References

  1. 1. Han J et al.. 2025. The Glycosyltransferase XYLT1 Activates NF-κB Signaling to Promote Metastasis of Early-Stage Lung Adenocarcinoma.. Cancer Res 85(9):1628-1643 PMID: 39992715
  2. 2. Alcaín FJ et al.. 2009. Sirtuin activators.. Expert Opin Ther Pat 19(4):403-14 PMID: 19441923
  3. 3. Sahin-Efe A et al.. 2012. Advances in adipokines.. Metabolism 61(12):1659-65 PMID: 23021039
  4. 4. Shin YJ et al.. 2025. ExermiR-129-3p Enhances Muscle Function by Improving Mitochondrial Activity Through PARP1 Inhibition.. J Cachexia Sarcopenia Muscle 16(2):e13823 PMID: 40254925
  5. 5. Blaney Davidson EN et al.. 2017. Osteoarthritis year in review 2016: biology.. Osteoarthritis Cartilage 25(2):175-180 PMID: 28100421
  6. 6. Zhou L et al.. 2022. The Role of SIRT3 in Exercise and Aging.. Cells 11(16) PMID: 36010672
  7. 7. Ciccone L et al.. 2022. Resveratrol-like Compounds as SIRT1 Activators.. Int J Mol Sci 23(23) PMID: 36499460
  8. 8. Masunaga T et al.. 2025. Reduction in Acetylation of Superoxide Dismutase 2 in Skeletal Muscle Improves Exercise Capacity in Mice With Heart Failure.. J Cachexia Sarcopenia Muscle 16(3):e13850 PMID: 40511632
Contact Us
*
*
*
*
How did you hear about us: